American biggies are joining hands with Chinese companies. AbbVie signed a deal with Simcere Zaiming for a multiple myeloma ...

Global Pharma Distributor, a leading provider of pharmaceutical distribution solutions, is building a new era in emergency ...

Despite a rocky start for many drugmakers at the start of last year, 2024’s fourth quarter saw just two of the top 25 global ...

India’s Contract Development and Manufacturing Organization (CDMO) market is witnessing a strong growth trajectory driven by ...

Friday's optimism in Wall Street brought cheer to the Nifty and Sensex in the Monday morning trade, as bulls took over the ...

Indian pharmaceutical CDMOs are anticipated to encounter minimal disruptions from the proposed US tariffs of 10-25 per cent.

Benchmark indices closed higher on Monday, boosted by pharmaceutical and financial stocks, with Sensex up 0.46% and Nifty 0.5 ...

Governments and global health groups are working to try to fill the most urgent gaps in the fight against diseases such as ...

In November 2024, Zealand Pharma presented detailed results from the Phase 1b 16-week multiple ascending dose (MAD) trial at ...

According to McKinsey & Company’s latest report, this growth is driven by pharma exports growing faster than the global average, is at a tipping point: emerging trends in Indian and global ...

Sun Pharma will acquire Checkpoint Therapeutics for $355 million, expected to close by Q2 2025. The deal strengthens Sun ...